SCHEMBL5659431

SCHEMBL5659431

COc1ccc(N2C(=O)C(c3cc(C)c(O)c(C)c3)(c3cc(C)c(O)c(C)c3)c3ccccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.44
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALOX5 P09917 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
ELANE P08246 1/20 0.39
ESR1 P03372 1/20 0.39
SCN9A Q15858 1/20 0.38
ADAMTS5 Q9UNA0 2/20 0.38
ADAMTS4 O75173 1/20 0.38
CNR1 P21554 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
MGLL Q99685 1/20 0.38
HSD11B1 P28845 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
HSD17B3 P37058 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656443 0.90 MAPT (0.44) MAPTALDH1A1KDM4ESCN9ACNR1
SCHEMBL5659374 0.88 PGR (0.42) PGRMAPTALDH1A1ALOX5PTGS1
SCHEMBL30929657 0.88 CNR1 (0.42) PGRMAPTALDH1A1ALOX5PTGS1
SCHEMBL5661596 0.88 CNR1 (0.42) PGRMAPTALDH1A1ALOX5PTGS1
SCHEMBL5662112 0.87 MAPT (0.41) MAPTALDH1A1KDM4ESCN9ACNR1
SCHEMBL5658446 0.86 SCN9A (0.39) MAPTALDH1A1KDM4EALOX5PTGS1
SCHEMBL5661100 0.86 MAPT (0.41) MAPTALDH1A1KDM4ESCN9ACNR1
SCHEMBL5656731 0.86 MAPT (0.41) MAPTALDH1A1KDM4ESCN9ACNR1
SCHEMBL5658916 0.85 MAPT (0.40) MAPTALDH1A1KDM4ESCN9ACNR1
SCHEMBL5658510 0.85 CNR1 (0.46) MAPTALDH1A1KDM4ESCN9ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 PGR 186/4885MAPT 3588/4885ALDH1A1 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.